The attached letter from the Georgia Drugs and Narcotics Agency (GDNA) has been posted on behalf of the Georgia Bureau of Investigation (GBI) regarding its new Georgia National Precursor Log Exchange (GANPLEx) program. During the 2016 Georgia General Assembly, House Bill 362 was passed, mandating that all over the counter pseudoephedrine (PSE) sales be reported to and maintained in a central electronic database. This database is to be overseen by the GBI, and the program being used is GANPLEx operated by the Appriss company.

The GBI has asked that the Board and GDNA pass along the attached letter which contains instructions on how pharmacies can sign up to start using GANPLEx. Most larger chain pharmacies are already using this system to record their PSE sales, meaning this letter is primarily addressed to the independent pharmacies and smaller chains which are not using GANPLEx.

The program is being provided at no cost to Georgia pharmacies. It will track all PSE sales, meaning that a pharmacy can enter the name of a person attempting to buy PSE to determine if that person has already purchased or exceeded their allowable quantity of PSE per day and per month. The law still allows law enforcement officers to access PSE data at any time.

This letter explains in detail what steps need to be followed in order to begin using GANPLEx. Please note that this program is maintained by Appriss, and any questions regarding GANPLEx need to be directed to the Appriss contacts contained in the letter.